ENDPOINTS

Updated: Zealand partners with Roche on amylin analog in a deal worth up to $5.3B

Zealand Pharma has finally found a partner. And according to the Danish pharma, the deal it announced with Roche on Wednesday for its amylin analog petrelintide is the biggest-ever licensing deal for an obesity candidate ...

Mar 12, 2025 - 11:48
 0
Updated: Zealand partners with Roche on amylin analog in a deal worth up to $5.3B
Zealand Pharma has finally found a partner. And according to the Danish pharma, the deal it announced with Roche on Wednesday for its amylin analog petrelintide is the biggest-ever licensing deal for an obesity candidate ...
Read More

Tags:

Previous Article

Updated: Zealand partners with Roche on its amylin analog in a deal worth up to ...

Next Article

How is sex determined? Scientists say it's complicated

Related Posts

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Feb 9, 2025  0

Merck dodges ‘failure to warn’ claims in federal Gardasil cases

Merck dodges ‘failure to warn’ claims in federal Gardas...

Mar 11, 2025  0

Beam shares promising first clinical data on gene editing treatment

Beam shares promising first clinical data on gene editi...

Mar 10, 2025  0